Objective: Preoperative clinical frailty is increasingly used as a surrogate for predicting postoperative outcomes. Patients undergoing major lower extremity amputation (LEA) carry a high risk of perioperative morbidity and mortality, including high 30-day mortality and readmission rates. We hypothesized that preoperative frailty would be associated with an increased risk of postoperative mortality and readmission.
Patients who undergo major lower extremity amputation (LEA) often have multiple comorbidities, and the prognosis is frequently poor, with mortality rates of 22% at 30 days and 44% at 1 year. 1 The long-term outlook is perhaps equally dismal: only 40% of patients who undergo amputation at the transtibial regain full mobility after 2 years, and 5-year mortality rates are as high as 77%. 1, 2 Previous investigations of prognostic factors have been limited to comparisons between surgical subspecialty fields and basic demographics. This is a potentially heterogeneous group of patients, many of whom suffer from chronic wasting, dysvascular syndromes, or other underlying conditions that contribute to an overall frail state. Frailty in medicine is scientifically defined as a biological syndrome that reflects a state of decreased physiologic reserve. 3 The exact pathophysiology is currently unknown, but proposed mechanisms include dysregulation of hormones and cytokines in the aging body, accumulation of insults to different organ systems caused by disease, and lifelong wear and tear. 3 For surgical fields, frailty is rapidly emerging as a potential method of risk-stratifying patients, and research is being performed to validate frailty assessments across a growing variety of subspecialties, operations, and populations. [4] [5] [6] [7] To date, frailty status has been identified as a predictor of poor outcomes in colorectal, cardiovascular, and gynecologic surgical procedures. Outcomes such as mortality, increased 30-day readmission rates, and a variety of other postoperative complications have been consistently correlated with an increase in frailty across different studies. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] These findings have led to recognition across a variety of fields that frail patients have worse outcomes than the nonfrail and that early identification of frailty is an important step in The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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Copyright Although a substantial portion of the patient population that undergoes LEA may meet most frailty criteria, no studies have provided evidence for a relationship between frailty and perioperative outcomes after amputation. In view of the significant 30-day and 1-year mortality rates associated with LEA overall, an assessment of frailty in these patients would be an important step toward the future use of frailty indices to risk stratify these patients and design potentially effective interventions to improve outcomes.
Ideally, interventions that address the underlying causes of frailty could be implemented. Alternatively, information regarding postoperative mortality and morbidity may be of clinical significance at the time of patient counseling: a frail patient with a predicted poor outcome may be better served by end-of-life care discussions with subsequent hospice services. Thus, the objective of this study was to investigate the prevalence of frailty and to examine the relationship between preoperative frailty status and postoperative morbidity and mortality in patients undergoing LEA.
METHODS
Study population. All patients who underwent transtibial or transfemoral amputations at a multihospital academic institution between December 2010 and March 2015 were identified. Patients aged <18 years were excluded. Patient medical records were interrogated to generate a frailty score using the mFI. Other sociodemographic variables collected included age, race, ethnicity, insurance status, employment status, and gender.
Data sources. Data were collected retrospectively by medical record review from prospectively maintained data sets. This represents composite data from a single vascular surgery academic group that covers five hospitals, including a major academic center, multiple community hospitals, and a large urban community hospital. Institutional Research Board approvals, along with a Health Insurance Portability and Accountability Act waiver, were obtained and maintained in active status throughout the conduct of this project. Institutional Review Board waivers for consent were obtained from all sites for the duration of this study.
Analysis. As previously described, the 11 historical parameters of the mFI were used to generate a frailty score: each component of the mFI is worth 1 point, and the maximum score is 11 (Table I) . 18 Briefly, the mFI is a retrospective method of assessment that measures frailty as an accumulation of deficits and can be performed in 2 minutes. It has been previously validated in large, national databases as well as in vascular surgery patient populations, making it an ideal instrument for this study. Components of the mFI were classified as present if they were documented in the medical record. Patients were determined to have an impaired functional status component if it was documented explicitly or if they were documented to live in a facility that provided support for activities of daily living (such as a nursing home). Impaired sensorium included acute and chronic delirium.
The primary outcome was all-cause mortality #30 days from a patient's last amputation, or whichever amputation was intended to be his or her last (as noted in the medical record). Secondary outcomes included unplanned revision, surgical site infection (SSI), stroke, renal failure, prolonged ventilation, sepsis, deep vein thrombosis, myocardial infarction, 30-day readmission, and 1-year mortality. Unplanned revision was defined as a return to the operating room for any reason related to the amputation stump. Outcomes other than 1-year mortality were classified as existing if they occurred #30 days from amputation. The definition for 30-day readmission was an unplanned readmission to any participating sites #30 days of discharge. One-year mortality data were collected from the medical record. A composite adverse events end point of SSI, stroke, renal failure, prolonged ventilation, sepsis, deep vein thrombosis, and myocardial infarction was generated to account for low event rates of each of the included outcomes. Patients who were considered lost to follow-up were censored at the time of their last recorded contact with the health care system.
Data were analyzed by descriptive and univariate statistics and then by inferential statistics. The differences in specific outcomes among subject groups based on
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Significance: This is a novel manuscript that describes frailty assessments in a single-center cohort of major lower extremity amputations. demographics, clinical characteristics, facility, and other variables were examined using c 2 and t-tests. The risk of specific outcome variables (eg, readmission and mortality) were also examined, and logistic regression models were used to identify factors associated with patient outcomes.
Multivariate logistic regression was performed comparing mFI score, sex, age, race, employment status, insurance status, amputation type, and the components of the mFI. Multivariate models were generated using stepwise selection with entry and exit criteria of 0.05. The effect of mFI on significant outcomes was assessed as an ordinal and as a categoric variable to confirm the linearity of the relationship. Kaplan-Meier survival curves were constructed to examine crude survival differences between individuals with differing mFI scores. The use of mFI >2 as a cutoff for frailty has been described previously. 19 This concept was applied to the Kaplan-Meier curves in an effort to provide a more easily interpretable survival analysis as well as to increase the statistical power by combining multiple mFI levels.
RESULTS
A total of 379 patients (64.0% male) who underwent major LEA were identified and included in the analysis (Table II) . The mean patient age was 59.1 6 15.0 years. The mean number of points scored on the mFI was 2.9 6 1.7 (range, 0-8; mode, 2; median, 3). The most common indications for amputation were ischemia/tissue loss (64.6%) and infection (18.2%). A transtibial amputation was performed in 51.8% of patients as the definitive treatment for their presenting clinical condition (Table II) . When a truncated mFI from 0 to 5 was used to account for low numbers of high-scoring patients, the most common mFI score was 2 (n ¼ 98), followed by $5 (n ¼ 73), 4 (n ¼ 70), 3 (n ¼ 66), 1 (n ¼ 37), and 0 (n ¼ 35; Table III ). The most common mFI component present was hypertension (78.9%), followed by diabetes mellitus (54.9%) and peripheral vascular disease (PVD; 54.1%).
Association between the mFI and 30-day mortality. Association between the mFI and additional outcomes. The overall 30-day readmission rate for the cohort was 22.7%, with increasing mFI score corresponding to increasing rates of readmission (c 2 ¼ 18.1158; P ¼ .0028; Table IV ). Nonwound-related issues resulted in 71.1% of readmissions, followed by wound-related issues in 28.9%. Among the wound-related issues were SSI, wound dehiscence, and poor wound healing. On (17) 10 (14) 10 (14) Medicaid 64 (17) 5 (14) 9 (24) 17 (17) 13 (20) Fig 1) . An adjusted survival curve separating patients into those with mFI #2 and >2 showed decreased survival in the mFI >2 group (Wilcoxon test statistic ¼ 8.3731; P ¼ .0038; Fig 2) .
DISCUSSION
This large single-center series of 379 patients found preoperative frailty status was a strong predictor of 30-day readmission after major LEA. With the current focus on frailty as a risk-stratification tool, these findings add to the growing body of evidence across multiple surgical specialties that the effects of frailty are measurable and meaningful as related to postoperative outcomes.
The association between frailty and 30-day readmission is consistent with previous findings in patients undergoing colorectal or cardiac procedures. 15 Not all of these findings, however, are consistent with the literature: multiple studies focused on vascular surgery populations have found significant relationships between frailty and 30-day mortality and composite adverse outcomes. Adverse events was defined as any postoperative incidence of 30-day mortality, 30-day readmission, unplanned revisions, surgical site infection (SSI), stroke, renal failure, prolonged ventilation, sepsis, deep vein thrombosis, and myocardial infarction. A possible reason for the lack of detected effect is variability in the definition of adverse events among the studies, especially the inclusion of events such as 30-day mortality and the breakdown of outcomes by different classification schemes. Several variables of interest that could have an effect on the relationship between mortality and mFI were not available in our data set, including presence of infection at the time of surgery, wound size, hemoglobin A 1c , smoking status, and nutritional status. Our analysis also did not account for bilateral LEAs because they represented <5% of our population. These missing variables could also explain the mild protective effect of age against unplanned revision. To our knowledge, this is the first study to examine the effect of frailty on postoperative outcomes in the population undergoing major LEA. These data do not depend on a large national patient data series and thus may not be reflective of national trends; consequently, the presented findings may be more applicable in a similar academic setting. Although large databases have significant value in increased power and sample size, a single academic center offers granular detail that may not be available in a national study. We consider the diverse indications for amputation to be one of the strengths of this study. Although a relatively small percentage of the study population underwent amputation for trauma-related reasons, almost half of the overall population had mFI scores of #2, mostly attributed to hypertension or diabetes. The traumatic amputation group was included to provide a better representation of the population undergoing amputations as a whole as well as to reflect that vascular, general, and orthopedic surgeons at our medical center perform these operations.
For similar reasons, we decided not to limit our analysis to only patients with PVD. We cannot rule out the possibility that some of the patients with diabetes also had PVD (and vice versa). Although this could be interpreted as a weakness of using a retrospective measure of frailty such as the mFI, we believe that it is actually a strength: rather than simply comparing dysvascular to nondysvascular patients, we acknowledge that this is a heterogeneous patient population and use one unifying concept to assess risk: frailty. This study adds to the growing body of evidence that frailty is a viable method of risk stratification, even in populations considered to be somewhat saturated with high-risk patients.
The retrospective nature of this study places some constraints on the definitions of several variables of the mFI, most notably patient independence and recent angina. These factors were taken into account when noted in the medical record, but a prospective study would conceivably have much greater fidelity of patient factors. The ease with which the mFI can be implemented, however, is a powerful argument for its widespread adaptation in medicine. Instead of the 15 to 30 minutes required to assess a patient's grip strength and walk time, which other scales use, the mFI score can be calculated in w2 minutes or less. Furthermore, because historical data are used to calculate mFI, a physician with a busy clinic could assess a patient at his or her convenience. However, the mFI needs to be validated in prospective trials before it can be used in such a setting. Whether the accumulation of deficits model of frailty or one using phenotypic measurements will emerge as the most effective method of frailty measurement remains unclear at this time, but a simple, easy, and quickly executed method is more likely to be widely adopted.
As stated above, the relatively small sample size of patients available may have contributed to lack of significance in several expected relationships and to inadequate power for subgroup analysis. The short follow-up period available in the data set limits the strength of inferences beyond 30 days.
Another concern is that the mFI does not account for differing levels of severity within components. For example, a patient with mild memory loss would receive the same score as a delirious patient. This could cause the mFI to have decreased discriminatory power when most of a patient's morbidities are cognitive in nature. PVD is highly prevalent in the population of patients undergoing LEA, and these patients often have much comorbidity. It is thus possible that the results are somewhat skewed towards worse outcomes, even though this patient sample included traumatic amputations as well as amputations done for diabetic foot infections.
Another drawback to the retrospective nature of this study is inconsistency in the medical record. Because different surgeons from various specialties may perform amputations at our institution, there were sometimes incomplete or different noted indications for patients between operations. However, all amputations were included for a more complete assessment of the patient population.
Fig 2.
Survival analysis of major lower extremity amputation (LEA) patients stratified by the modified Frailty Index (mFI) score #2 and >2. Survival time is measured in days. Wilcoxon test statistic ¼ 8.3731; P ¼ .0038. bi_mfi of 0 signifies a mFI less than or equal to 2, while bi_mfi of 1 signifies a mFI greater than 2. For mFI #2, there were 170 patients at 0 days, 160 at 30 days, and 103 patients at 365 days. The number of censored patients was 52. For mFI >2, there were 209 patients at 0 days, 193 at 30 days, and 112 at 365 days. The number of censored patients was 54. The standard error did not exceed 10% for the specified time period.
CONCLUSIONS
The association between frailty and 30-day readmission should be given extra weight when confronted with the frail patient who requires an amputation. Although it is widely known that these patients bear some of the heaviest burdens in terms of comorbidities, there is often little special consideration of the needs of new amputees while in the hospital. Easing the transition to home, either with enhanced recovery programs or some other focused follow-up initiative, should be considered by surgeons before discharging such patients. In addition, the evidence added by this study strengthens the argument that reimbursement guidelines should take patient frailty status into account because frail patients clearly have a higher likelihood of returning in need of further medical care.
Surgeons who appropriately operate on high-risk patients should not be penalized for doing so, but identification of such patients will be a challenge moving forward. To date, reimbursement levels for operations with expected complication rates have been procedurally generated, but in reality, preoperative factors may play a much more important role in the outcomes than technical aspects. Ideally, these data will aid physicians in determining which patients will benefit most from additional postoperative support as well as assist those who set reimbursement levels for specific patient populations and procedures.
